allergy
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participation in MIPS 1 and 2 and informed consent
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| atopic diseases infections biochemical immune parameters faeces parameters | — |
Secondary
| Measure | Time frame |
|---|---|
| safety: functional gastrointestinal diseases / symptoms | — |
Countries
Netherlands